Advertisement

Topics

Karolinska Development AB and Uminova Invest AB Company Profile

11:12 EST 22nd November 2017 | BioPortfolio

Karolinska Development manages one of the largest portfolios of life science companies in Europe.


News Articles [284 Associated News Articles listed on BioPortfolio]

Karolinska Development: Investing in innovative business

Jim Van Heusden of Karolinska speaks to Fintan Walton of PharmaVentures about his strategy for the company’s growth, his ambitions for investment opportunities outside Sweden, and the challenges and...

Karolinska Development AB (publ): Karolinska Development realizes value increase in the portfolio company BioArctic through a partial exit and receives SEK 35 million

STOCKHOLM 6 November 2017. Karolinska Development today announces that the company has sold 1.5 million shares to a total amount of SEK 35 million in the portfolio company BioArctic Neurosciences ...

Karolinska to own 7.7% of Xspray Pharma after listing

Nordic life sciences investment firm Karolinska Development is set to receive a significant chunk of…

Karolinska Development AB Umecrine Cognition Appoints Dr. To Its Board Of Directors

STOCKHOLM - September 5, 2017. Umecrine Cognition AB, a Karolinska Development (Nasdaq Stockholm: KDEV) portfolio company in clinical development with a novel GABAA receptor modulator for the treat...

Patheon to Invest $45M to Expand Capabilities

Will invest in commercial and development spray drying and flexible manufacturing solutions

Invest in Spain: Attracting Foreign Business

In this episode of PharmaTelevision News Review, Fintan Walton talks with Ana Arias, Life Science Manager at Invest in Spain. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • In...

Feinstein, Karolinska license rights to start-up Applied Immunotherapeutics

The Feinstein Institute for Medical Research and Karolinska Institute granted Applied Immunotherapeutics Inc. (start-up developing treatments for autoimmune and inflammatory diseases) rights to discov...

Karolinska Development AB ??? Interim Report (January-June 2017) ??? Invitation To Conference Call And Webcast

STOCKHOLM - August 24, 2017. Karolinska Development AB (Nasdaq Stockholm: KDEV) will publish its Interim Report - January-June 2017 on August 29, 2017 after market closure. The company will also ho...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Cordran [Watson Pharma, Inc.]

Cordran® Tape Flurandrenolide Tape, USP For the Physician Rx only Revised: May 2010

Flexbumin [Baxter Healthcare Corporation]

FLEXBUMIN 25% Albumin (Human), USP, 25% Solution in GALAXY single-dose container

Keralyt [Summers Laboratories Inc]

Keralyt® Shampoo (salicylic acid) 6% w/applicator   FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE.

PubMed Articles [820 Associated PubMed Articles listed on BioPortfolio]

Coordinating Leader-Follower Supply Chain with Sustainable Green Technology Innovation on Their Fairness Concerns.

Sustainable green technology innovation is essential in all the stages of the supply chain development. The members of the supply chain in each stage need to invest in sustainable green technology inn...

Parents' willingness to invest in their children's oral health.

This study aimed to evaluate parents' Willingness to Invest (WTI) in their children's oral health in terms of money, visits to a dental practice, and brushing minutes. Objectives were to assess the as...

Sleep quality after modified uvulopalatopharyngoplasty: Results from the SKUP3 randomized controlled trial.

To investigate whether uvulopalatopharyngoplasty (UPPP) improves sleep quality in patients with Obstructive Sleep Apnea (OSA) using the Functional Outcomes of Sleep Questionnaire (FOSQ) and the Karoli...

Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.

The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we s...

Pacing and Self-Regulation: Important Skills for Talent Development in Endurance Sports.

Pacing has been characterized as a multi-faceted goal-directed process of decision-making in which athletes need to decide how and when to invest their energy during the race, a process essential for ...

Clinical Trials [1502 Associated Clinical Trials listed on BioPortfolio]

INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo in Patients With Brain Hemorrhage

Objective: The primary objective of this multicenter prospective registry is to provide additional safety, technical outcomes and clinical outcomes data for minimally invasive endoscopic s...

A Comparison of Weighted Vest Exercise and Strength Training

The purpose of this study is to evaluate two types of exercise therapy designed to improve muscle power and mobility: weighted vest exercise vs. progressive resistance training.

Effects of Cash Transfers on Severe Acute Malnutrition

Cash transfer, aims to strengthen food security for vulnerable households by giving families enough purchasing power to consume an adequate and balanced diet, maintain a good standard of h...

INfusion VErsus STimulation in Parkinson's Disease

Both Continuous intrajejunal Levodopa Infusion (CLI) and Deep Brain Stimulation (DBS) are accepted therapies for the treatment of advanced Parkinson's disease (PD). To date, no comparative...

INVEST: Minimally Invasive Endoscopic Surgery vs. Medical Management in Supratentorial Intraparenchymal Hemorrhage

The primary aim of minimally invasive surgery (MIS) for supratentorial intracranial hemorrhage is to achieve an atraumatic evacuation of blood products from the brain to prevent the second...

Companies [643 Associated Companies listed on BioPortfolio]

Karolinska Development AB and Uminova Invest AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Karolinska Development AB PUBL

Managing one of the largest portfolios of life science research companies in Europe, Karolinska Development AB is a new type of company focused on filling the innovation gap within the pharmaceuti...

Karolinska Development AB (publ), and BioChromix AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Karolinska Development AB and Axelar AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique business model, the company cost efficiently guides the commercialization of world ...

Karolinska Development AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique, highly cost efficient business model, the management team guides the commercializa...

More Information about "Karolinska Development AB and Uminova Invest AB" on BioPortfolio

We have published hundreds of Karolinska Development AB and Uminova Invest AB news stories on BioPortfolio along with dozens of Karolinska Development AB and Uminova Invest AB Clinical Trials and PubMed Articles about Karolinska Development AB and Uminova Invest AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Karolinska Development AB and Uminova Invest AB Companies in our database. You can also find out about relevant Karolinska Development AB and Uminova Invest AB Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record